Top

Tag: aGvHD


FDA, Regulations

FDA approves first drug to prevent graft-versus-host disease

December 16, 2021

Via: PMLiVE

Huge strides have been made since then and haematopoietic stem cell transplantation (HSCT) is now an effective treatment –even a cure– for haematological malignancies and other non-malignant haematological diseases. Yet, up to 70% of patients that receive stem cell transplants, […]